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Abstract 10 
Mammalian glutamate transporters are crucial players in neuronal communication as they 11 
perform neurotransmitter reuptake from the synaptic cleft. Besides L-glutamate and L-aspartate, 12 
they also recognize D-aspartate, which might participate in mammalian neurotransmission and/or 13 
neuromodulation. Much of the mechanistic insight in glutamate transport comes from studies of the 14 
archaeal homologues GltPh from Pyrococcus horikoshii and GltTk from Thermococcus kodakarensis. 15 
Here, we show that GltTk transports D-aspartate with identical Na
+ 
: substrate coupling 16 
stoichiometry as L-aspartate, and that the affinities (Kd and Km) for the two substrates are similar. 17 
We determined a crystal structure of GltTk with bound D-aspartate at 2.8 Å resolution. Comparison 18 
of the L- and D-aspartate bound GltTk structures revealed that D-aspartate is accommodated with 19 
only minor rearrangements in the structure of the binding site. The structure explains how the 20 
geometrically different molecules L- and D-aspartate are recognized and transported by the protein 21 
in the same way.  22 
 23 
Introduction 24 
Mammalian excitatory amino acid transporters (EAATs) are responsible for clearing the 25 
neurotransmitter glutamate from the synaptic cleft (for review see (Grewer et al., 2014; Takahashi 26 
et al., 2015; Vandenberg and Ryan, 2013)). EAATs are secondary transporters that couple 27 
glutamate uptake to co-transport of three sodium ions and one proton and counter-transport of one 28 
potassium ion (Levy et al., 1998; Owe et al., 2006; Zerangue and Kavanaugh, 1996). EAATs 29 
transport L-glutamate, L- and D-aspartate with similar affinity (Arriza et al., 1994). 30 
D-aspartate is considered as a putative mammalian neurotransmitter and/or neuromodulator 31 
(Brown et al., 2007; D’Aniello et al., 2011; Spinelli et al., 2006) (reviewed in (D’Aniello, 2007; 32 
Genchi, 2017; Ota et al., 2012)). Such a role is also proposed for L-aspartate (Cavallero et al., 33 
2009), however this is still a matter of debate (Herring et al., 2015). Both stereoisomers bind to and 34 
activate N-methyl-D-aspartate receptors (NMDARs) (Patneau and Mayer, 1990) and might be 35 
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involved in learning and memory processes (reviewed in (Errico et al., 2018; Errico and Usiello, 36 
2017; Katane and Homma, 2011; Ota et al., 2012)).  37 
Although it is well established that EAATs take up D-aspartate (Arriza et al., 1994; Gundersen et 38 
al., 1993), structural insight in the binding mode of the enantiomer is lacking. The best structurally 39 
characterized members of the glutamate transporter family are the archaeal homologues GltPh and 40 
GltTk (Akyuz et al., 2015; Boudker et al., 2007; Guskov et al., 2016; Jensen et al., 2013; Reyes et 41 
al., 2013, 2009; Scopelliti et al., 2018; Verdon et al., 2014; Verdon and Boudker, 2012; Yernool et 42 
al., 2004), which share 32-36% sequence identity with eukaryotic EAATs (Jensen et al., 2013; 43 
Slotboom et al., 1999; Yernool et al., 2004). In contrast to EAATs, GltPh and GltTk are highly 44 
selective for aspartate over glutamate, and couple uptake only to co-transport of three sodium ions 45 
(Boudker et al., 2007; Groeneveld and Slotboom, 2010; Guskov et al., 2016). Despite these 46 
differences, the amino acid residues in the substrate-binding sites of mammalian and prokaryotic 47 
glutamate transporters are highly conserved (Boudker et al., 2007; Jensen et al., 2013). The first 48 
structures of human members of the glutamate transporter family (Canul-Tec et al., 2017; Garaeva 49 
et al., 2018), showed that the substrate-binding sites are indeed highly similar among homologues 50 
(Figure 2—figure supplement 1).  51 
Here we present the structure of GltTk with the enantiomeric substrate D-aspartate. The crystal 52 
structure was obtained in the outward-facing state with the substrate oriented in a very similar mode 53 
as L-aspartate, showing that the two enantiomers bind almost identically regardless of the mirrored 54 
spatial arrangement of functional groups around the chiral C atom. 55 
 56 
Results 57 
Affinity of D-aspartate and stoichiometry of sodium binding to GltTk 58 
Using Isothermal Titration Calorimetry (ITC) we determined the binding affinities of D-59 
aspartate to GltTk in the presence of varying concentrations of sodium ions (Figure 1A, Table 1). 60 
The affinity of the transporter for D-aspartate was strongly dependent on the concentration of 61 
sodium, similar to what has been reported for L-aspartate binding to GltPh and GltTk (Boudker et al., 62 
2007; Hänelt et al., 2015; Jensen et al., 2013; Reyes et al., 2013). At high sodium concentration 63 
(500 mM), the Kd values of GltTk for D- and L-aspartate binding level off to 374 ± 30 nM and 62 ± 64 
3 nM, respectively. The ΔH values for binding of both substrates were favorable, with a more 65 
negative value of ~ 1 kcal mol
-1
 for L-aspartate, indicating a better binding geometry for L- than for 66 
D-aspartate. For both substrates, the ΔS contribution was unfavorable (Table 1). When plotting the 67 
observed Kd values for L- and D-aspartate against the sodium concentration (on logarithmic scales), 68 
the slopes of both curves in the lower limit of the sodium concentration are close to -3, indicating 69 
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that binding of both compounds is coupled to the binding of three sodium ions (Boudker et al., 70 
2007; Lolkema and Slotboom, 2015) (Figure 1B). 71 
To test whether D-aspartate is a transported substrate, purified GltTk was reconstituted into 72 
proteoliposomes and uptake of [
3
H]-D-aspartate was assayed. GltTk catalyzed transport of the 73 
radiolabeled substrate into the proteoliposomes. The Km for transport was 1.1 ± 0.11 M at a 74 
sodium concentration of 100 mM (Figure 1C). This value is comparable to the Km for L-aspartate 75 
uptake under the same conditions (0.75 ± 0.17 M). The stoichiometry Na+ : D-aspartate was 76 
determined by flux measurements of radiolabeled D-aspartate at different membrane voltages 77 
(Fitzgerald et al., 2017). Depending on the concentrations of Na
+
 and D-aspartate on either side of 78 
the membrane, the imposed voltages either lead to flux of radiolabeled D-aspartate across the 79 
membrane (accumulation into or depletion from the lumen), or does not cause net flux (when the 80 
voltage equals the equilibrium potential) (Fitzgerald et al., 2017). The equilibrium potentials for 81 
different possible stoichiometries are calculated by: 82 















where n and m are the stoichiometric coefficients for Na
+
 and substrate S, respectively. Membrane 84 
voltages were chosen that would match the equilibrium potential for stoichiometries of 2:1 (-78 85 
mV), 3:1 (-39 mV) or 4:1 (-26 mV), and flux of radiolabeled D-aspartate was measured (Figure 86 
1D). At -78 mV D-aspartate was taken up into the lumen; at -26 mV it was released from the 87 
liposomes; and at -39 mV there was little flux. From this data, we conclude that D-aspartate is most 88 
likely symported with three sodium ions. However, the flux was not exactly zero at the calculated 89 
equilibrium potential of -39 mV for 3:1 stoichiometry. This small deviation could be caused by 90 
systematic experimental errors, or by leakage or slippage (Parker et al., 2014; Shlosman et al., 91 
2018). To exclude that it was caused specifically by D-aspartate, we repeated the experiment using 92 
radiolabeled L-aspartate. The equilibrium potentials for the experiments using D- and L-aspartate 93 
were identical, showing that the two stereoisomers use the same coupling stoichiometry. 94 
 95 
Similar mode of enantiomers binding 96 
We determined a crystal structure of GltTk in complex with D-aspartate at 2.8 Å resolution 97 
(Figure 2A, B). The obtained structure is highly similar to the previously described GltTk and GltPh 98 
structures with the transport domains in the outward-oriented occluded state. Comparison of the 99 
GltTk structures in complex with L- and D-aspartate revealed a highly similar binding mode of the 100 
substrates with analogous orientation of amino and carboxyl groups. Despite the impossibility to 101 
superimpose two enantiomers, D- and L-aspartate are capable of forming almost identical hydrogen 102 
bonding networks with conserved amino acid residues of the substrate-binding site (Figure 2C). 103 
There are only small changes in the positions of the Cα atoms and C carboxyl groups due to the 104 
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constitutional differences. However, this divergence leads to only minor changes in the interaction 105 
network, consistent with the comparable Kd and ΔH values determined by ITC (Table 1). 106 
Three peaks of electron density (Figure 2D; Figure 2—figure supplement 2) located at the same 107 
positions as three sodium ions in the GltTk complex with L-aspartate (Guskov et al., 2016) most 108 
probably correspond to sodium ions, consistent with a 3:1 Na
+
 : D-aspartate coupling stoichiometry 109 
(Figure 1B, D). 110 
 111 
Discussion 112 
Most proteins selectively bind a single stereoisomer of their substrates (for a review see (Nguyen 113 
et al., 2006)). On the other hand, some proteins are able to bind different stereoisomers of a ligand, 114 
which is believed to be possible due to different binding modes, because enantiomers cannot be 115 
superimposed in the three-dimensional space and thus cannot interact with the binding site 116 
identically.  117 
Based on three- and four-point attachment models (Easson and Stedman, 1933; Mesecar and 118 
Koshland, 2000; Ogston, 1948) it has been suggested that stereoisomers can bind in the same site 119 
but with significant differences. This hypothesis was supported by crystal structures of enzymes 120 
with different enantiomeric substrates (Brem et al., 2016; Sabini et al., 2008), including 121 
enantiomeric amino acids (Aghaiypour et al., 2001; Bharath et al., 2012; Driggers et al., 2016; 122 
Temperini et al., 2006). In contrast, the binding poses of enantiomers in some other enzymes are 123 
remarkably similar, for instance in aspartate/glutamate racemase EcL-DER, where active site forms 124 
pseudo-mirror symmetry (Liu et al., 2016). 125 
To our knowledge GltTk is the first amino acid transporter for which the binding of enantiomeric 126 
substrates has been characterized. The only other transporter for which structures have been 127 
determined in the presence of D- and L-substrates is the sodium-alanine symporter AgcS. However, 128 
in that case, limited resolution prevented determination of the absolute orientation of bound 129 
enantiomers (Ma et al., 2019). In the substrate-binding site of GltTk, L- and D-aspartate take similar 130 
poses leading to almost identical networks of contacts. Since mirror imaged substrates inevitably 131 
have differences in angles between donors and acceptors of hydrogen bonds, the binding affinities 132 
are not identical, with 4-6 times higher Kd of the GltTk-D-aspartate complex in comparison with L-133 
aspartate (Table 1). Similar differences in binding affinities between these enantiomers were also 134 
found for the GltPh homologue (Boudker et al., 2007). The higher Kd values for the D-aspartate 135 
enantiomer might be explained by a higher dissociation rate (koff) in comparison with L-aspartate, 136 
that was shown in kinetic studies of sodium
 
and aspartate binding on GltPh (Ewers et al., 2013; 137 
Hänelt et al., 2015). GltTk couples binding and transport of three sodium ions to one D-aspartate 138 
molecule (Figure 1B, D), the same number as for L-aspartate. Although the affinity for D-aspartate 139 
is lower than for L-aspartate, the binding of D-aspartate is not accompanied by a loss of sodium 140 
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binding sites, which is in line with the observation that none of the sodium binding sites are directly 141 
coordinated by the substrate L-aspartate. In the crystal structure of GltTk with D-aspartate peaks of 142 
density were resolved at positions corresponding to the three sodium ions in the L-aspartate bound 143 
GltTk structure (Figure 2D) (Guskov et al., 2016). Altogether our data suggest that the mechanism of 144 
D- and L-aspartate transport in GltTk is most probably identical.  145 
Mammalian glutamate transporters take up D-aspartate, L-glutamate and L-aspartate with similar 146 
micromolar affinity, but have significantly lower affinity (millimolar) for D-glutamate (Arriza et al., 147 
1997, 1994). In the absence of the structures of human SLC1A transporters with different 148 
stereoisomeric substrates, one can only speculate why EAATs can readily bind and transport both 149 
L- and D-aspartate, but only L-glutamate. It seems that the extra methylene group in D-glutamate 150 
compared to D-aspartate could cause sterical clashes within the binding site (Figure 2— figure 151 
supplement 3), which might affect affinity of binding. 152 
 153 
 154 
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Protein purification and crystallization 158 
GltTk was expressed and purified as described previously (Guskov et al., 2016). It was shown that 159 
L-aspartate binds to GltTk only if sodium ions are present, and the protein purified in absence of 160 
sodium ions is in the apo state (Jensen et al., 2013). For crystallization with D-aspartate the apo 161 
protein was purified by size exclusion chromatography (SEC) on a Superdex 200 10/300 GL (GE 162 
Healthcare) column equilibrated with buffer containing 10 mM Hepes KOH, pH 8.0, 100 mM KCl, 163 
0.15% DM. Crystals of GltTk with D-aspartate were obtained in presence of 300 mM NaCl, 300 µM 164 
D-aspartate (Sigma-Aldrich, 99%) by the vapour diffusion technique (hanging drop) at 5°C by 165 
mixing equal volumes of protein (7 mg ml
-1
) and reservoir solution (20% glycerol, 10% PEG 4000, 166 
100 mM Tris/bicine, pH 8.0, 60 mM CaCl2, 60 mM MgCl2, 0.75% n-octyl-b-D-glucopyranoside 167 
(OG)).  168 
 169 
Data collection and structure determination. 170 
Crystals were flash-frozen without any additional cryo protection and data sets were collected at 171 
100K at the beamline ID29 (ESRF, Grenoble). The data were indexed, integrated and scaled in 172 
XDS (Kabsch, 2010) and the structure was solved by Molecular Replacement with Phaser (McCoy 173 
et al., 2007) using structure of GltTk (PDB ID 5E9S) as a search model. Manual model rebuilding 174 
and refinement were carried out in COOT (Emsley et al., 2010) and Phenix refine (Afonine et al., 175 
2012). Data collection and refinement statistics are summarized in Table 2. Coordinates and 176 
structure factors for GltTk have been deposited in the Protein Data Bank under accession codes PDB 177 
6R7R. All structural figures were produced with an open-source version of PyMol. 178 
 179 
Isothermal titration calorimetry  180 
ITC experiments were performed at a constant temperature of 25°C using an ITC200 calorimeter 181 
(MicroCal). Varying concentrations of the indicated substrates (in 10 mM Hepes KOH, pH 8.0, 100 182 
mM KCl, 0.15% DM and indicated sodium concentrations) were titrated into a thermally 183 
equilibrated ITC cell filled with 250 μl of 3-20 μM GltTk supplemented with 0 to 1000 mM NaCl. 184 
Data were analyzed using the ORIGIN-based software provided by MicroCal. 185 
 186 
Reconstitution into proteoliposomes 187 
A solution of E. coli total lipid extract (20 mg ml
-1
 in 50 mM KPi, pH 7.0) was extruded with a 400-188 
nm-diameter polycarbonate filter (Avestin, 11 passages) and diluted with the same buffer to a final 189 
concentration of 4 mg ml
-1
. The lipid mixture was destabilized with 10% Triton-X100. Purified 190 
GltTk and the destabilized lipids were mixed in a ratio of 1:1600 or 1:250 (protein : lipid) and 191 
incubated at room temperature for 30 minutes. Bio-beads were added four times (25 mg ml
-1
, 15 mg 192 
ml
-1
, 19 mg ml
-1
, 4 mg ml
-1
 lipid solution) after 0.5 h, 1 h, overnight and 2 h incubation, 193 
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respectively, on a rocking platform at 4°C. The Bio-beads were removed by passage over an empty 194 
Poly-Prep column (Bio-Rad). The proteoliposomes were collected by centrifugation (20 min, 195 
298,906 g, 4°C), subsequently resuspended in 50 mM KPi, pH 7.0 to the concentration of the 196 
protein 33.4 µg ml
-1
 and freeze-thawed for four cycles. The proteoliposomes were stored in liquid 197 
nitrogen until subsequent experiments. 198 
 199 
Uptake assay 200 
Stored proteoliposomes with reconstitution ratio of 1:1600 were thawed and collected by 201 
centrifugation (20 min, 298,906 g, 4°C), the supernatant was discarded and the proteoliposomes 202 
were resuspended in buffer containing 10 mM KPi, pH 7.5, 300 mM KCl. The internal buffer was 203 
exchanged by three cycles of freezing in liquid nitrogen and thawing, and finally extruded through a 204 
polycarbonate filter with 400 nm pore size (Avestin, 11 passages). The proteoliposomes were 205 
finally pelleted by centrifugation (20 min, 298,906 g, 4°C) and resuspended to the concentration of 206 
the protein 625 ng µl
-1
. 2 µl of proteoliposomes were diluted 100 times in reaction buffer containing 207 
10 mM KPi, pH 7.5, 100 mM NaCl, 200 mM Choline-Cl, 3 µM valinomycin and 0.2-15 µM D-208 
aspartate (each concentration point contained 0.2 µM [
3
H]-D-aspartate). After 15 s the reaction was 209 
quenched by adding 2 ml of ice-cold buffer (10 mM KPi, pH 7.5, 300 mM KCl) and immediately 210 
filtered on nitrocellulose filter (Protran BA 85-Whatman filter), finally the filter was washed with 2 211 
ml of quenching buffer. The filters were dissolved in scintillation cocktail and the radioactivity was 212 
measured with a PerkinElmer Tri-Carb 2800RT liquid scintillation counter. 213 
 214 
 Measuring transporter equilibrium potentials 215 
Stored proteoliposomes with reconstitution ratio of 1:250 were thawed and collected by 216 
centrifugation (20 min, 298,906 g, 4°C), the supernatant was discarded and the proteoliposomes 217 
were resuspended to a concentration of 10 mg ml
-1
 of lipids in buffer containing 20 mM Hepes/Tris, 218 
pH 7.5, 200 mM NaCl, 50 mM KCl, 10 μM D-aspartate (containing 1 μM [3H]-D-aspartate). The 219 
internal buffer was exchanged by freeze-thawing and extrusion as described above. The experiment 220 
was started by diluting the proteoliposomes 20 times into a buffer containing 20 mM Hepes/Tris, 221 
pH 7.5, 200 mM NaCl, 3 μM valinomycin, varying concentrations of KCl and Choline Cl were 222 
added in order to obtain the desired membrane potential as shown in (Figure 1—source data 1).  223 
 224 
After 1, 2 and 3 minutes the reaction was quenched with ice-cold quenching buffer containing 20 225 
mM Hepes/Tris, pH 7.5, 250 mM Choline Cl and immediately filtered on nitrocellulose filter 226 
(Protran BA 85-Whatman filter), finally the filter was washed with 2 ml of quenching buffer. The 227 
initial amount of radiolabeled aspartate was measured by filtering the proteoliposomes immediately 228 
after diluting them in quenching buffer. The filters were dissolved in scintillation cocktail and the 229 
 8 
radioactivity was measured with a PerkinElmer Tri-Carb 2800RT liquid scintillation counter. The 230 
equilibrium, or reversal, potential, Erev, for each condition was calculated as described in (Fitzgerald 231 
et al., 2017).  232 
 9 
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Figures and Tables 391 
 392 
 393 
Figure 1. Binding and transport of D-aspartate by GltTk. (A) ITC analysis of D-aspartate binding to 394 
GltTk in presence of 300 mM NaCl (Kd of 0.47 ± 0.17 µM). Inserts show no D-aspartate binding in 395 
absence of NaCl. (B) Sodium and aspartate binding stoichiometry. Logarithmic plot of Kd values 396 
(nM) for L-aspartate (black squares; slope is -2.8 ± 0.4; taken for reference from (Guskov et al., 397 
2016)) and D-aspartate (grey circles; slope is -2.9 ± 0.2) against logarithm of NaCl concentration 398 
(mM). The negative slope of the double logarithmic plot (red line) in the limit of low sodium 399 
concentrations indicates the number of sodium ions that bind together with aspartate. Error bars 400 
represent the ± SD from at least three independent measurements. (C) GltTk transport rate of D-401 
aspartate in presence of 100 mM NaCl. The solid line reports the fit to an Michaelis-Menten 402 
hyperbolic curve with Km of 1.1 ± 0.11 µM. Error bars represent the ± SD from duplicate 403 
experiments. (D) Determination of Na
+ 
: aspartate coupling stoichiometry in GltTk using equilibrium 404 
potential measurement. The uptake or efflux of radiolabeled aspartate was determined by 405 
comparing the luminal radioactivity associated with the liposomes after 2 minutes of 406 
incubation with the radioactivity initially present (Δcpm). Grey circles and black squares show the 407 
measurements for D- and L-aspartate, respectively. The solid and dashed lines are the best linear 408 
regression for the D- and L-aspartate data, respectively. The 95% confidence interval for D-409 
aspartate is displayed by grey curves. Numbers in parentheses are the coupling stoichiometries 410 
expected to give zero flux conditions for each membrane voltage. Error bars represent the ± SD 411 
obtained in 5 replicates.  412 
Source data 1. Final concentrations of internal and external buffer used in each reversal potential 413 





Figure 2. The crystal structure of GltTk with D-aspartate. The model contains one protein molecule 419 
in the asymmetric unit with the substrate present in each protomer of the homotrimer. (A) Cartoon 420 
representation of the homotrimer viewed from the extracellular side of the membrane. Lines 421 
separate protomers. Each protomer consists of the scaffold domain (pale green) and the transport 422 
domain. In the transport domain HP1 (yellow), HP2 (red), TMS7 (orange) are shown. D-aspartate is 423 
shown as black sticks and Na
+
 ions as purple spheres. Like in most GltPh structures a part of the 424 
long flexible loop 3-4 between the transport and scaffold domain is not visible. It is indicated by a 425 
dashed connection. (B) A single protomer is shown in the membrane plane. (C) Comparison of the 426 
substrate-binding site of GltTk in complex with L-aspartate (grey; PDB code 5E9S) and D-aspartate 427 
(black). Cartoon representation; substrates and contacting amino acid residues are shown as sticks; 428 
 15 
hydrogen bonds are shown as dashed lines. The GltTk structures with D- and L-aspartate can be 429 
aligned with Cα-RMSD = 0.38 Å for the three transport domains. (D) Composite omit map (cyan 430 
mesh) for D-aspartate (contoured at 1) and sodium ions (2) calculated using simulated annealing 431 
protocol in Phenix (Terwilliger et al., 2008). Color coding in all panels is the same. 432 
Figure supplement 1. Superposition of substrate binding sites of L-aspartate bound GltTk and 433 
thermostabilized human EAAT1. 434 
Figure supplement 2. Superposition of substrate and sodium binding sites in L-aspartate and D-435 
aspartate bound GltTk. 436 
Figure supplement 3. Model of glutamate binding in EAAT1. 437 
 438 
 439 
Table 1. Thermodynamic parameters of D- and L-aspartate binding at high (300 mM) and low (75 440 
mM) Na
+ 
concentration.  441 
Substrate/ Na
+
 Kd (µM) 
 
ΔH (cal mol-1) ΔS (cal mol-1 K-1) 
L-aspartate/ 300 mM NaCl 0.12 ± 0.04 -1.61 (± 0.08) x 10
4
 -22.1 ± 2.2 
D-aspartate/ 300 mM NaCl 0.47 ± 0.17 -1.48 (± 0.11) x 10
4
 -20.6 ± 3.6 
L-aspartate/ 75 mM NaCl 1.04 ± 0.39 -1.22 (± 0.13) x 10
4
 -13.2 ± 5.2 
D-aspartate/ 75 mM NaCl 5.66 ± 1.59 -1.14 (± 0.41) x 10
4
 -14.3 ± 14.3* 
*At low Na
+
 concentrations high errors prevented accurate measuring of ΔS values. 442 
 443 
 444 
Table 2. Data collection and refinement statistics.  445 
 GltTk D-Asp 
Data collection  
Space group  
Cell dimensions  
a, b, c (Å)  
a, b, g (°)  
Resolution (Å)  
Rmeas  
CC1/2 





Resolution (Å)  
No. reflections  
Rwork / Rfree (%)  








116.55, 116.55, 314.77  























R.m.s. deviations  
Bond lengths (Å) 









*Values in parentheses are for the highest-resolution shell. 446 
 447 
 448 
Figure 2—figure supplement 1. 449 
Superposition of substrate binding sites of L-aspartate bound GltTk and thermostabilized human 450 
EAAT1. All side chains involved in L-aspartate binding are highly conserved and identical in GltTk 451 
(PDB code 5E9S; L-aspartate is shown as green sticks) and EAAT1 (PDB code 5LM4; pale cyan). 452 
GltTk numbering. Different corresponding side chains of EAAT1 are shown in parentheses. In the 453 





Figure 2—figure supplement 2. 459 
Superposition of substrate and sodium binding sites in L-aspartate and D-aspartate bound GltTk. 460 
Substrate and sodium ions are shown as sticks and spheres in green for L-aspartate structure (PDB 461 
code 5E9S; grey cartoon) and black for D-aspartate structure (HP1, HP2, TMS7 are shown in 462 
yellow, red and orange, respectively). The composite omit map for L-aspartate and sodium ions is 463 
shown as green mesh contoured at 3; the black mesh represents map for D-aspartate (contoured at 464 
1) and corresponding sodium ions (2). The composite omit maps are calculated using the 465 




Figure 2—figure supplement 3. 470 
Model of glutamate binding in EAAT1. Superimposed structures of EAAT1 with L-aspartate (grey 471 
cartoon and green sticks; PDB code 5LLU) and GltTk with D-aspartate (black sticks). D-glutamate 472 
(cyan sticks and semi-transparent spheres) and L-glutamate (yellow sticks) were modeled in such a 473 
way that Cα, amino group and α carboxyl of D- and L-glutamate were superimposed with 474 
corresponding atoms of D- or L-aspartate in GltTk and EAAT1 structures, respectively. The model 475 
shows that D-glutamate might clash with highly conservative T402 (NMDGT motif of TMS7; T317 476 
 17 
in GltTk) and R479 (TMS8; R401 in GltTk) of EAAT1 that both coordinate Cβ carboxyl group of L-477 
aspartate. In contrast L-glutamate might be placed with orientation similar to L-aspartate, 478 
preventing clashes. Modeling was performed using COOT (Emsley et al., 2010). 479 
 480 
Figure 1—source data 1. Final concentrations of internal and external buffer used in each reversal 481 
potential experiment after diluting the proteoliposomes. Proteoliposomes were loaded with 20 mM 482 
HEPES/Tris, pH 7.5, 200 mM NaCl, 10μM L- or D-aspartate, 50 mM KCl and diluted 20 fold in 483 
buffer containing 20 mM HEPES/Tris, pH 7.5, 200 mM NaCl, 35.0/26.4/19.2 mM CholineCl, 484 
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